marijuana stocks news

Terra Tech Corp. (TRTC)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014
Total Revenue 763   1,507   1,315   3,712  
Cost of Revenue 535 1,321 1,251 3,811
Gross Profit 229   187   64   (100)
Operating Expenses
Research Development
Selling General and Administrative 2,331 4,197 8,035 3,892
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (2,103) (4,010) (7,971) (3,992)
Income from Continuing Operations
Total Other Income/Expenses Net 143 1,094 (1,162) (329)
Earnings Before Interest And Taxes (1,959) (2,916) (9,134) (4,321)
Interest Expense 189 258 388 234
Income Before Tax (2,148) (3,174) (9,521) (4,555)
Income Tax Expense 2 13
Minority Interest 74 291
Net Income From Continuing Ops (2,077) (2,896) (9,521) (4,555)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (2,077) (2,896) (9,521) (4,555)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (2,077) (2,896) (9,521) (4,555

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GrowGeneration Corp. (GRWG) to Participate in the 26th Annual ICR Conference

GrowGeneration to Participate in the 26th Annual ICR Conference GrowGeneration Corp. (NASDAQ:…

$EAPH and BMV Medica Close on Joint Distribution Agreement

Easton Pharmaceuticals and BMV Medica Close on Joint Distribution Agreement for Injectable…

Village Farms International, Inc. (VFF) International Announces Pure Sunfarms’ Receipt of License Amendment to Supply Cannabis Products

Village Farms International Announces Pure Sunfarms’ Receipt of License Amendment to Supply…

Tetra Bio-Pharma Inc. (TBPMF) Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials

Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing…